Metabolic pathway targeting by transcription factor overexpression
AssigneeExxonMobil Research and Engineering Company
InventorsJessica Kristof, Rekha Seshadri
Life of this patent
Estimating the term…
Loading patent…
AssigneeExxonMobil Research and Engineering Company
InventorsJessica Kristof, Rekha Seshadri
Estimating the term…
The invention provides microorganisms such as cyanobacteria genetically engineered to express proteins that include transcription factor domains for upregulation of lipid biosynthetic pathways. In addition to expression a gene encoding a transcription factor domain protein, the recombinant microorganisms can express at least one exogenous gene that encodes a polypeptide for the production of a fatty acid, fatty acid derivative, or triglyceride. Also included are methods of producing a fatty acid, fatty acid derivative, or triglyceride using the engineered microorganisms described herein as well as nucleic acid molecules encoding novel transcription factor domain proteins.
A recombinant cyanobacterium comprising an exogenous nucleic acid molecule encoding a transcription factor domain protein, wherein the cyanobacterium produces a greater amount of at least one free fatty acid or at least one fatty acid derivative than does a cyanobacterium that does not contain an exogenous nucleic acid molecule encoding the transcription factor domain protein.
An isolated or recombinant nucleic acid molecule comprising a nucleic acid sequence encoding a polypeptide comprising an amino acid sequence having at least about 85% sequence identity to SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO:10, or SEQ ID NO:12.
Dependencies are inferred from the claim text.